Hydrochloric Acid → 5-Nitro-2-(4-oxopiperidin-1-yl)benzonitrile
反応式
Cl[C:2]1[CH:9]=[CH:8][C:7]([N+:10]([O-:12])=[O:11])=[CH:6][C:3]=1[C:4]#[N:5].Cl.O.[NH:15]1[CH2:20][CH2:19][C:18](=[O:21])[CH2:17][CH2:16]1.C(N(CC)CC)C.Cl>C(#N)C>[N+:10]([C:7]1[CH:8]=[CH:9][C:2]([N:15]2[CH2:20][CH2:19][C:18](=[O:21])[CH2:17][CH2:16]2)=[C:3]([CH:6]=1)[C:4]#[N:5])([O-:12])=[O:11]参加物
6
実験手順
2-Chloro-5-nitrobenzonitrile (15 g), 4-piperidone monohydrate hydrochloride (13.9 g) and triethylamine (25 ml) were added to acetonitrile (100 ml), and the mixture was stirred at a refluxing temperature for 1.5 h. 0.5 N Aqueous hydrochloric acid solution (200 ml) was added to the reaction mixture to allow crystallization to give the title compound (16.1 g), melting point: 109° C.
後処理
- customcrystallization
出典と根拠
- ORDレコード
- ord-1aceaba6d95e4aebb59e834c4eaf6878
- 出典データセット
- uspto-grants-2006_03
- 特許番号
- US07015218B1
反応ノート
読み込み中…